RTsafe and RT-IDea International BV sign exclusive agreement for distribution
RTsafe, a medical technology company focused on improving the safety and accuracy of radiotherapy for cancer and other medical conditions, announced that RT-IDea International BV will be the exclusive distributor of RTsafe’s products in Belgium, Luxemburg, Sweden and Norway. About RTsafe RTsafe is a medical technology company that has …
Lees verder "RTsafe and RT-IDea International BV sign exclusive agreement for distribution"
Newsitem on RT-Safe
Personalize your stereotactic quality assurance solutions with a PseudoPatient™ and improve your end to end QA. RTsafe is providing innovative, 3D printed pseudo in-vivo phantoms and remote dosimetry services. Their solutions will provide cancer centers an elegant quality assurance (QA) solution by elevating confidence in the end-to-end accuracy of stereotactic …
Newsitem on Gold Anchor
Groundbraking publication on randomized trial on ultra-hypofractionated radiotherapy, the HYPO-RT-PC phase 3! Fiducial markers will become even more important when applying ultra-hypofractionated radiotherapy for prostate cancer. Congratulations to all the 12 Swedish and Danish centers that have contributed to the HYPO-RT-PC phase 3 trial! As the first published randomized …